Información financiera

Debates Datos técnicos Previsión Estacionales

Beneficio bruto de EVER SUPREME BIO TECHNOLOGY CO LTD.

Datos anuales

2017

2018

2019

2020

2021

2022

2023

TTM

‪‪−200,00 M‬‬

‪0,00‬

‪‪200,00 M‬‬

‪‪400,00 M‬‬

‪‪600,00 M‬‬

Periodo

Valor

Cambio

% cambio

TTM

‪‪528,82 M‬‬

+‪‪62,61 M‬‬

+‪13,43‬%

2023

‪‪466,21 M‬‬

+‪‪70,58 M‬‬

+‪17,84‬%

2022

‪‪395,63 M‬‬

+‪‪171,06 M‬‬

+‪76,17‬%

2021

‪‪224,58 M‬‬

+‪‪260,90 M‬‬

—

2020

‪‪−36,32 M‬‬

‪‪−28,00 M‬‬

‪−336,59‬%

2019

‪‪−8,32 M‬‬

‪‪−1,47 M‬‬

‪−21,43‬%

2018

2017

Datos trimestrales

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪45,00 M‬‬

‪‪90,00 M‬‬

‪‪135,00 M‬‬

‪‪180,00 M‬‬

Periodo

Valor

Cambio

% cambio

Q3 '24

‪‪151,18 M‬‬

+‪‪39,42 M‬‬

+‪35,27‬%

Q2 '24

‪‪111,76 M‬‬

+‪‪12,28 M‬‬

+‪12,35‬%

Q1 '24

‪‪99,48 M‬‬

‪‪−66,91 M‬‬

‪−40,21‬%

Q4 '23

‪‪166,39 M‬‬

+‪‪8,38 M‬‬

+‪5,30‬%

Q3 '23

‪‪158,01 M‬‬

+‪‪64,51 M‬‬

+‪69,00‬%

Q2 '23

‪‪93,50 M‬‬

+‪‪45,19 M‬‬

+‪93,54‬%

Q1 '23

‪‪48,31 M‬‬

‪‪−75,06 M‬‬

‪−60,84‬%

Q4 '22

‪‪123,37 M‬‬

+‪‪12,61 M‬‬

+‪11,39‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20